54 research outputs found
A Cool and Inflated Progenitor Candidate for the Type Ib Supernova 2019yvr at 2.6 Years Before Explosion
We present Hubble Space Telescope imaging of a pre-explosion counterpart to
SN 2019yvr obtained 2.6 years before its explosion as a type Ib supernova (SN
Ib). Aligning to a post-explosion Gemini-S/GSAOI image, we demonstrate that
there is a single source consistent with being the SN 2019yvr progenitor
system, the second SN Ib progenitor candidate after iPTF13bvn. We also analyzed
pre-explosion Spitzer/IRAC imaging, but we do not detect any counterparts at
the SN location. SN 2019yvr was highly reddened, and comparing its spectra and
photometry to those of other, less extinguished SNe Ib we derive
mag for SN 2019yvr. Correcting photometry
of the pre-explosion source for dust reddening, we determine that this source
is consistent with a and K star. This relatively cool photospheric
temperature implies a radius of 320, much larger
than expectations for SN Ib progenitor stars with trace amounts of hydrogen but
in agreement with previously identified SN IIb progenitor systems. The
photometry of the system is also consistent with binary star models that
undergo common envelope evolution, leading to a primary star hydrogen envelope
mass that is mostly depleted but seemingly in conflict with the SN Ib
classification of SN 2019yvr. SN 2019yvr had signatures of strong circumstellar
interaction in late-time (150 day) spectra and imaging, and so we consider
eruptive mass loss and common envelope evolution scenarios that explain the SN
Ib spectroscopic class, pre-explosion counterpart, and dense circumstellar
material. We also hypothesize that the apparent inflation could be caused by a
quasi-photosphere formed in an extended, low-density envelope or circumstellar
matter around the primary star.Comment: 22 pages, 9 figures, submitted to MNRA
Multi-Messenger Astronomy with Extremely Large Telescopes
The field of time-domain astrophysics has entered the era of Multi-messenger
Astronomy (MMA). One key science goal for the next decade (and beyond) will be
to characterize gravitational wave (GW) and neutrino sources using the next
generation of Extremely Large Telescopes (ELTs). These studies will have a
broad impact across astrophysics, informing our knowledge of the production and
enrichment history of the heaviest chemical elements, constrain the dense
matter equation of state, provide independent constraints on cosmology,
increase our understanding of particle acceleration in shocks and jets, and
study the lives of black holes in the universe. Future GW detectors will
greatly improve their sensitivity during the coming decade, as will
near-infrared telescopes capable of independently finding kilonovae from
neutron star mergers. However, the electromagnetic counterparts to
high-frequency (LIGO/Virgo band) GW sources will be distant and faint and thus
demand ELT capabilities for characterization. ELTs will be important and
necessary contributors to an advanced and complete multi-messenger network.Comment: White paper submitted to the Astro2020 Decadal Surve
Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis
BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London
The Gravity Collective: A Search for the Electromagnetic Counterpart to the Neutron Star-Black Hole Merger GW190814
We present optical follow-up imaging obtained with the Katzman Automatic
Imaging Telescope, Las Cumbres Observatory Global Telescope Network, Nickel
Telescope, Swope Telescope, and Thacher Telescope of the LIGO/Virgo
gravitational wave (GW) signal from the neutron star-black hole (NSBH) merger
GW190814. We searched the GW190814 localization region (19 deg for the
90th percentile best localization), covering a total of 51 deg and 94.6%
of the two-dimensional localization region. Analyzing the properties of 189
transients that we consider as candidate counterparts to the NSBH merger,
including their localizations, discovery times from merger, optical spectra,
likely host-galaxy redshifts, and photometric evolution, we conclude that none
of these objects are likely to be associated with GW190814. Based on this
finding, we consider the likely optical properties of an electromagnetic
counterpart to GW190814, including possible kilonovae and short gamma-ray burst
afterglows. Using the joint limits from our follow-up imaging, we conclude that
a counterpart with an -band decline rate of 0.68 mag day, similar to
the kilonova AT 2017gfo, could peak at an absolute magnitude of at most
mag (50% confidence). Our data are not constraining for ''red'' kilonovae and
rule out ''blue'' kilonovae with (30% confidence). We
strongly rule out all known types of short gamma-ray burst afterglows with
viewing angles 17 assuming an initial jet opening angle of
and explosion energies and circumburst densities similar to
afterglows explored in the literature. Finally, we explore the possibility that
GW190814 merged in the disk of an active galactic nucleus, of which we find
four in the localization region, but we do not find any candidate counterparts
among these sources.Comment: 86 pages, 9 figure
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world.
Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231.
Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05â2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001).
Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication
Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world
Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.
Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.
Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.
Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis.
Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection
- âŠ